(Q44169352)

30 November 2017

title

Hepcidin and GDF15 in anemia of multiple myeloma (English)

1 reference

30 November 2017

Shuchong Mei

1

1 reference

30 November 2017

Huaquan Wang

2

1 reference

30 November 2017

Rong Fu

3

1 reference

30 November 2017

Wen Qu

4

1 reference

30 November 2017

Limin Xing

5

1 reference

30 November 2017

Guojin Wang

6

1 reference

30 November 2017

Jia Song

7

1 reference

30 November 2017

Hong Liu

8

1 reference

30 November 2017

Lijuan Li

9

1 reference

30 November 2017

Xiaoming Wang

10

1 reference

30 November 2017

Yuhong Wu

11

1 reference

30 November 2017

Jin Guan

12

1 reference

30 November 2017

Erbao Ruan

13

1 reference

30 November 2017

Zonghong Shao

14

1 reference

30 November 2017

publication date

23 July 2014

1 reference

International Journal of Hematology

30 November 2017

published in

1 reference

30 November 2017

volume

100

1 reference

30 November 2017

issue

3

1 reference

30 November 2017

page(s)

266-273

1 reference

https://scigraph.springernature.com/pub.10.1007/s12185-014-1626-7

30 November 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Hepcidin and multiple myeloma related anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Recent advances in understanding the pathogenesis of anemia in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Erythropoietin and iron-restricted erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Immunoassay for human serum hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Involvement of hepcidin in the anemia of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Different regulatory elements are required for response of hepcidin to interleukin-6 and bone morphogenetic proteins 4 and 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Lack of the bone morphogenetic protein BMP6 induces massive iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Sequential evaluation of serum hepcidin in anemic myeloma patients: Study of correlations with myeloma treatment, disease variables, and anemia response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Interleukin-6 induces hepcidin expression through STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Serum growth differentiation factor 15 levels in newly diagnosed multiple myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Ineffective erythropoiesis in mutant mice with deficient pyruvate kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Macrophage inhibitory cytokine MIC-1 is upregulated by short-wavelength light in cultured normal human dermal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

Autocrine formation of hepcidin induces iron retention in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1626-7

The Implications of Anemia in Multiple Myeloma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25052873

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

High-dose epoetin alfa as induction treatment for severe anemia in multiple myeloma patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25052873

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12185-014-1626-7

1 reference

30 November 2017

1 reference